Annovis Bio says NYSE accepted plan to regain compliance

Annovis Bio (ANVS) announced it received notification from the New York Stock Exchange that the NYSE has accepted the company’s previously-submitted plan to regain compliance with the NYSE’s continued listing standards relating to minimum market capitalization and stockholders’ equity. The NYSE granted the company an 18-month period from Annovis Bio’s receipt of the NYSE’s Notice of Noncompliance dated March 26 to regain compliance with the continued listing standards.